Onabotulinum toxin A treatment of cervicogenic headache: A randomised, double-blind, placebo-controlled crossover study
- 7 February 2011
- journal article
- research article
- Published by SAGE Publications in Cephalalgia
- Vol. 31 (7), 797-807
- https://doi.org/10.1177/0333102411398402
Abstract
Aims: Preliminary reports regarding injections in the neck of onabotulinum toxin A have been positive in cervicogenic headache (CeH). The aim was to perform the first methodologically rigorous trial. Methods: A randomised, placebo-controlled, patient-, injector- and evaluator-blinded crossover study included 28 adult patients with a long-standing and treatment-resistant CeH. After a baseline period, injections of either onabotulinum toxin A or placebo were given in fixed sites in the neck muscles on the pain side. Second injections were given after ≥8 weeks. Patients were thereafter followed for another 8 weeks. A detailed headache calendar was filled in, and patients were followed with quality-of-life (QoL) questionnaires, algometry and neck mobility measurements. Results: There was no significant difference between verum and placebo in a mixed linear model analysis ( p = 0.084) with regard to the primary end-point, reduction of days with moderate to severe headache. Six patients withdrew from the study before the second injections, but an intention-to-treat (ITT) analysis gave a similar result ( p = 0.27). There were no significant differences favouring verum in any of the secondary efficacy measures. Side-effects of onabotulinum toxin A were minor and short-lasting. Conclusion: Onabotulinum toxin A in neck muscles does not seem to be beneficial in CeH.Keywords
This publication has 52 references indexed in Scilit:
- Peripheral Nerve Blocks and Trigger Point Injections in Headache Management – A Systematic Review and Suggestions for Future ResearchHeadache: The Journal of Head and Face Pain, 2010
- Cervicogenic Headache: Evidence That the Neck is a Pain GeneratorHeadache: The Journal of Head and Face Pain, 2010
- Cervicogenic Headache: The Neck Is a Generator: ConHeadache: The Journal of Head and Face Pain, 2010
- OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trialCephalalgia, 2010
- Design, analysis, and presentation of crossover trialsTrials, 2009
- Prevalence of Secondary Chronic Headaches in a Population-Based Sample of 30-44-Year-Old Persons. The Akershus Study of Chronic HeadacheCephalalgia, 2008
- Whiplash Headache is Transitory Worsening of a Pre-Existing Primary HeadacheCephalalgia, 2008
- Cervicogenic Headache Caused by Myofascial Trigger Points in the Sternocleidomastoid: A Case ReportCephalalgia, 2007
- Safety, effectiveness, and duration of effect of BOTOX after switching from Dysport for blepharospasm, cervical dystonia, and hemifacial spasmCurrent Medical Research and Opinion, 2005
- “Cervicogenic Headache”: Clinical ManifestationCephalalgia, 1987